Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | LIVN | LIVANOVA PLC | Healthcare | 567,500.0 | $34.9M | 1.29% | NEW | — | $61.53 | +20.0% |
| 22 | GSK | GSK PLC | Healthcare | 639,000.0 | $31.3M | 1.16% | NEW | — | $49.04 | +4.8% |
| 23 | GERN | GERON CORP | Healthcare | 23,290,000.0 | $30.7M | 1.13% | NEW | — | $1.32 | -3.0% |
| 24 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 60,000.0 | $29.2M | 1.08% | NEW | — | $487.25 | +16.7% |
| 25 | IMVT | IMMUNOVANT INC | Healthcare | 1,110,000.0 | $28.2M | 1.04% | NEW | — | $25.42 | +34.3% |
| 26 | PCVX | VAXCYTE INC | Healthcare | 608,958.0 | $28.1M | 1.04% | NEW | — | $46.14 | +2.5% |
| 27 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 70,000.0 | $27.8M | 1.03% | NEW | — | $397.65 | -25.2% |
| 28 | INSP | INSPIRE MED SYS INC | Healthcare | 299,399.0 | $27.6M | 1.02% | NEW | — | $92.23 | -52.5% |
| 29 | VCEL | VERICEL CORP | Healthcare | 764,000.0 | $27.5M | 1.01% | NEW | — | $36.01 | -3.6% |
| 30 | ARGX | ARGENX SE | Healthcare | 31,726.0 | $26.7M | 0.98% | NEW | — | $840.95 | -4.1% |
| 31 | — | RAPT THERAPEUTICS INC | — | 764,000.0 | $25.9M | 0.95% | NEW | — | $33.87 | — |
| 32 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 175,982.0 | $25.0M | 0.92% | NEW | — | $141.83 | +10.5% |
| 33 | — | KINIKSA PHARMACEUTICALS INTL | — | 587,000.0 | $24.2M | 0.89% | NEW | — | $41.25 | — |
| 34 | EDAP | EDAP TMS S A | Healthcare | 7,309,254.0 | $24.0M | 0.89% | NEW | — | $3.29 | +30.7% |
| 35 | TFX | TELEFLEX INCORPORATED | Healthcare | 190,000.0 | $23.2M | 0.85% | NEW | — | $122.04 | +8.8% |
| 36 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 1,219,394.0 | $23.1M | 0.85% | NEW | — | $18.97 | -7.7% |
| 37 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 910,000.0 | $22.6M | 0.83% | NEW | — | $24.82 | +31.8% |
| 38 | — | INHIBIKASE THERAPEUTICS INC | — | 10,875,000.0 | $22.3M | 0.82% | NEW | — | $2.05 | — |
| 39 | PHVS | PHARVARIS N V | Healthcare | 702,052.0 | $19.5M | 0.72% | NEW | — | $27.75 | +7.0% |
| 40 | IVVD | INVIVYD INC | Healthcare | 7,708,727.0 | $19.0M | 0.70% | NEW | — | $2.47 | -55.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%